Debra Patt, MD, PhD, MBA

Texas Oncology

Austin, Texas

Articles

Frontline Treatment Standards for HER2+ mBC

July 21, 2021

Debra Patt, MD, PhD, MBA, describes the frontline standards of care and the factors involved in deciding on a treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer.